Keynote and Invited speakers

speaker8 Daniele Lilleri

Laboratori Sperimentali di Ricerca-Area Trapiantologica
Fondazione IRCCS Policlinico San Matteo

He is scientist at Experimental Research Laboratories-Transplantation Area, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy since 2010. He received his MD from “Università degli Studi di Pavia” in 1998. He worked as a fellow at Viral Diagnostic Service, Fondazione IRCCS Policlinico San Matteo, Pavia from 1998 to 2003 and received the specialization diploma in Microbiology and Virology from “Università degli Studi di Milano” in 2003, and continued his research activity at Viral Diagnistic Service until 2010. He was visiting scientist at Institute for Research in Biomedicine, Bellinzona, Switzerland from 2011 to 2016. He held lectures for the School of Medicine and for the School of Specialization in Microbiology and Virology, “Facoltà di Medicina e Chirurgia, Università degli Studi di Pavia”. He received the 2007 European Society for Clinical Virology “Abbott Diagnostic Award” for original contributions in the field of viral diagnosis. His research activity was initially focused on the validation of molecular assays for diagnosis and monitoring of human cytomegalovirus (HCMV) infections in immunocompetent and immunocompromised subjects. Subsequently he studied the HCMV-specific humoral and cell-mediated immune responses in immunocompetent and immunocompromised subjects. He contributed to the identification of the main pathogenetic features of HCMV infection. He was principal investigator of the research projects: “Dissection of the immune response to human cytomegalovirus glycoprotein complexes: perspective for the development of a candidate subunit vaccine” and “Human cytomegalovirus: prognostic factors of virus transmission to the fetus and congenital disease”; he is currently coordinator of the research project: "Pathogenesis and prevention of non-primary human cytomegalovirus infection".


Volledige programa

CMV 2017: the 6th International congenital CMV conference/16th International CMV/betaherpesvirus workshop in 2017<